
NOC · NYSE
Expected to report Oct 20, 2026 — estimated from last year’s reporting date.
Consensus is $7.26 EPS for Sep 2026 across 6 estimates, ranging $7.02 to $7.49.
Northrop Grumman’s second quarter was a demand and backlog quarter with a strong EPS beat, but not a clean operating-margin quarter. Revenue of $10.88 billion increased 5% year over year and 10% from the prior quarter, while diluted EPS of $7.68 exceeded the $6.84 consensus by 12.28%. Operating income was $1.10 billion, down 23% from the year-ago period but up from $989 million in Q1. Net earnings declined 7% year over year to $1.09 billion, versus $875 million in Q1. The year-ago comparison included a $231 million gain from the training-services divestiture and a $1.04 per-share benefit.
The defining positive was demand visibility: $20.0 billion of net awards, led by a $7.6 billion Sentinel award, lifted backlog to a record $104.7 billion. Aeronautics grew 13% and Mission Systems expanded its margin to 15.4%, offsetting weakness in Defense and Space, where SiAW and GEM 63XL cost revisions weighed on profitability. A 6.3% effective tax rate, versus 17.7% last year, also supported EPS. Management raised full-year sales and MTM-adjusted EPS guidance, but reaffirmed operating-income and cash-flow targets, suggesting the upside is concentrated in growth, tax and pension-related items rather than broad-based margin expansion.
Sales increased $525 million year over year to $10.876 billion, with growth across Aeronautics, Defense, Mission and Space. Operating income declined $329 million to $1.096 billion, and operating margin fell 370 basis points to 10.1%. The comparison was distorted by the $231 million training-services divestiture gain recorded in the second quarter of 2025, but underlying segment operating income also fell $61 million to $1.158 billion and the FAS/CAS operating adjustment declined $56 million to $7 million. Sequentially, revenue rose from $9.88 billion and operating income from $989 million, reflecting stronger volume and the absence of first-quarter effects rather than a broad margin recovery.
The quarter’s EPS benefited materially from below-normal taxes. Tax expense fell 71% to $74 million as the effective tax rate declined to 6.3% from 17.7%, principally because of a $115 million remeasurement of uncertain tax positions following developments with the IRS, alongside research credits. The company also recorded a $166 million non-operating FAS pension benefit and a $35 million gain on the sale of an investment within other income. Second-quarter operating cash flow was $1.280 billion, up 47% year over year, and adjusted free cash flow rose 54% to $978 million after $302 million of capital expenditures. For the first half, however, operating cash flow remained negative at $376 million and adjusted free cash flow at negative $845 million, reflecting working-capital investment.